Li Y, Hsiao S, Murakami M, Huang Y, Chang Y, Hung T
ACS Pharmacol Transl Sci. 2024; 7(1):161-175.
PMID: 38230272
PMC: 10789147.
DOI: 10.1021/acsptsci.3c00217.
Wu C, Murakami M, Li Y, Huang Y, Chang Y, Hung T
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004460
PMC: 10674403.
DOI: 10.3390/ph16111595.
Wu C, Li Y, Murakami M, Hsiao S, Lee Y, Huang Y
Int J Mol Sci. 2023; 24(18).
PMID: 37762275
PMC: 10531071.
DOI: 10.3390/ijms241813972.
Li Y, Murakami M, Huang Y, Hung T, Wang S, Wu Y
Int J Mol Sci. 2022; 23(21).
PMID: 36361555
PMC: 9658017.
DOI: 10.3390/ijms232112763.
Wu C, Murakami M, Wu Y, Lin C, Li Y, Huang Y
Biomed Pharmacother. 2022; 149:112922.
PMID: 36068781
PMC: 10506422.
DOI: 10.1016/j.biopha.2022.112922.
Branebrutinib (BMS-986195), a Bruton's Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents.
Wu C, Murakami M, Wu Y, Chi Y, Hsiao S, Huang Y
Front Cell Dev Biol. 2021; 9:699571.
PMID: 34350184
PMC: 8326665.
DOI: 10.3389/fcell.2021.699571.
The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs.
Wu C, Hung T, Lusvarghi S, Chu Y, Hsiao S, Huang Y
Biochem Pharmacol. 2021; 188:114516.
PMID: 33713643
PMC: 8291035.
DOI: 10.1016/j.bcp.2021.114516.
Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
Wu C, Hung T, Hsiao S, Huang Y, Hung L, Yu Y
Cancers (Basel). 2020; 12(6).
PMID: 32466597
PMC: 7352346.
DOI: 10.3390/cancers12061366.
Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.
Wu C, Lusvarghi S, Hsiao S, Liu T, Li Y, Huang Y
J Nat Prod. 2020; 83(5):1461-1472.
PMID: 32347726
PMC: 7402219.
DOI: 10.1021/acs.jnatprod.9b01022.
MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs.
Wu C, Lusvarghi S, Tseng P, Hsiao S, Huang Y, Hung T
Am J Cancer Res. 2020; 10(1):164-178.
PMID: 32064159
PMC: 7017726.
Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.
Wu C, Hsiao S, Huang Y, Hung L, Yu Y, Chang Y
Cancers (Basel). 2020; 12(1).
PMID: 31941029
PMC: 7017071.
DOI: 10.3390/cancers12010195.
The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
Wu C, Lusvarghi S, Wang J, Hsiao S, Huang Y, Hung T
Int J Mol Sci. 2020; 21(1).
PMID: 31905792
PMC: 6981391.
DOI: 10.3390/ijms21010238.
Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines.
Wu C, Lusvarghi S, Wang J, Hsiao S, Huang Y, Hung T
Mol Pharm. 2019; 16(7):3040-3052.
PMID: 31117741
PMC: 6620786.
DOI: 10.1021/acs.molpharmaceut.9b00274.
The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Hsiao S, Lusvarghi S, Huang Y, Ambudkar S, Hsu S, Wu C
Cancer Lett. 2019; 445:34-44.
PMID: 30639533
PMC: 8132113.
DOI: 10.1016/j.canlet.2019.01.001.
Cariprazine, A Dopamine D₂/D₃ Receptor Partial Agonist, Modulates ABCG2-Mediated Multidrug Resistance in Cancer.
Hussein N, Ashby Jr C, Amawi H, Nyinawabera A, Vij A, Khare V
Cancers (Basel). 2018; 10(9).
PMID: 30181510
PMC: 6162716.
DOI: 10.3390/cancers10090308.
The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines.
Hsiao S, Murakami M, Yeh N, Li Y, Hung T, Wu Y
Cancer Lett. 2018; 434:81-90.
PMID: 30031116
PMC: 6109596.
DOI: 10.1016/j.canlet.2018.07.022.
SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines.
Wu C, Murakami M, Hsiao S, Liu T, Yeh N, Li Y
Cancer Lett. 2018; 433:259-272.
PMID: 30026175
PMC: 6084781.
DOI: 10.1016/j.canlet.2018.07.004.
Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines.
Wu C, Hsiao S, Murakami M, Lu M, Li Y, Hsieh C
Cancer Lett. 2017; 409:56-65.
PMID: 28893612
PMC: 5634936.
DOI: 10.1016/j.canlet.2017.08.035.
Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter.
Wu C, Hsiao S, Murakami M, Lu Y, Li Y, Huang Y
Mol Pharm. 2017; 14(8):2805-2814.
PMID: 28641010
PMC: 7830752.
DOI: 10.1021/acs.molpharmaceut.7b00334.
Overexpression of ATP-Binding Cassette Subfamily G Member 2 Confers Resistance to Phosphatidylinositol 3-Kinase Inhibitor PF-4989216 in Cancer Cells.
Wu C, Murakami M, Hsiao S, Chou A, Li Y, Huang Y
Mol Pharm. 2017; 14(7):2368-2377.
PMID: 28597653
PMC: 7830714.
DOI: 10.1021/acs.molpharmaceut.7b00277.